Lactacystin enhances cisplatin sensitivity in resistant human ovarian cancer cell lines via inhibition of DNA repair and ERCC-1 expression.

Cellular and molecular biology (Noisy-le-Grand, France)

Volumn 47 Online Pub, Issue , 2001, Pages

  Li, Q Q ^a   Yunmbam, M K ^a   Zhong, X ^a   Yu, J J ^a   Mimnaugh, E G ^a   Neckers, L ^a   Reed, E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTINEOPLASTIC AGENT; CISPLATIN; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; DNA; DNA BINDING PROTEIN; DRUG DERIVATIVE; ENDONUCLEASE; ERCC1 PROTEIN, HUMAN; LACTACYSTIN; MESSENGER RNA; MULTIENZYME COMPLEX; PROTEASOME; PROTEIN; RNA;

ARTICLE; CELL CULTURE; DNA DAMAGE; DNA REPAIR; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; OVARY TUMOR;

ACETYLCYSTEINE; ANTINEOPLASTIC AGENTS; CISPLATIN; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA DAMAGE; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; ENDONUCLEASES; FEMALE; GENE EXPRESSION; HUMANS; MULTIENZYME COMPLEXES; OVARIAN NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR CELLS, CULTURED;

EID: 0004920274     PISSN: 01455680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)